Dopamine genes and ADHD
- PMID: 10654656
- DOI: 10.1016/s0149-7634(99)00062-7
Dopamine genes and ADHD
Abstract
Family, twin, and adoption studies have documented a strong genetic basis for ADHD/HKD, but these studies do not identify specific genes linked to the disorder. Molecular genetic studies can identify allelic variations of specific genes that are functionally associated with ADHD/HKD, and dopamine genes have been the initial candidates based on the site of action of the stimulants drugs, which for a half century have provided the primary pharmacological treatment for ADHD/HKD. Two candidate dopamine genes have been investigated and reported to be associated with ADHD/HKD: the dopamine transporter (DAT1) gene [Cook et al., American Journal of Human Genetics 1995;56:993-998, Gill et al., Molecular Psychiatry 1997;2:311-313] and the dopamine receptor D4 (DRD4) gene [LaHoste et al., Molecular Psychiatry 1996;1:121-124: Smalley et al., 1998;3:427-430; Swanson et al., Molecular Psychiatry 1998;3:38-41]. Speculative hypotheses [Swanson and Castellanos, NIH Consensus Development Conference: Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, November 1998. p. 37-42] have suggested that specific alleles of these dopamine genes may alter dopamine transmission in the neural networks implicated in ADHD/HKD (e.g. that the 10-repeat allele of the DAT1 gene may be associated with hyperactive re-uptake of dopamine or that the 7-repeat allele of the DRD4 gene may be associated with a subsensitive postsynaptic receptor). These and other variants of the dopamine hypothesis of ADHD will be discussed.
Similar articles
-
Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene.Am J Med Genet. 2001 Jul 8;105(5):471-8. doi: 10.1002/ajmg.1408. Am J Med Genet. 2001. PMID: 11449401
-
Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.Mol Psychiatry. 2004 Jul;9(7):711-7. doi: 10.1038/sj.mp.4001466. Mol Psychiatry. 2004. PMID: 14699430
-
Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder.Am J Med Genet B Neuropsychiatr Genet. 2004 Jul 1;128B(1):84-9. doi: 10.1002/ajmg.b.30079. Am J Med Genet B Neuropsychiatr Genet. 2004. PMID: 15211638
-
Genetic basis of attention deficit and hyperactivity.Br J Psychiatry. 1999 Feb;174:105-11. doi: 10.1192/bjp.174.2.105. Br J Psychiatry. 1999. PMID: 10211163 Review.
-
[Distribution of DRD4 and DAT1 alleles from dopaminergic system in a mixed Chilean population].Rev Med Chil. 2003 Feb;131(2):135-43. Rev Med Chil. 2003. PMID: 12708251 Review. Spanish.
Cited by
-
Attention deficits linked with proclivity to explore while foraging.Proc Biol Sci. 2024 Feb 28;291(2017):20222584. doi: 10.1098/rspb.2022.2584. Epub 2024 Feb 21. Proc Biol Sci. 2024. PMID: 38378153
-
Adverse effects of early-life stress: focus on the rodent neuroendocrine system.Neural Regen Res. 2024 Feb;19(2):336-341. doi: 10.4103/1673-5374.377587. Neural Regen Res. 2024. PMID: 37488887 Free PMC article. Review.
-
Accelerated high frequency rTMS induces time-dependent dopaminergic alterations: a DaTSCAN brain imaging study in healthy beagle dogs.Front Vet Sci. 2023 May 16;10:1154596. doi: 10.3389/fvets.2023.1154596. eCollection 2023. Front Vet Sci. 2023. PMID: 37261109 Free PMC article.
-
Strong Binding of Phytochemicals to the Catalytic Domain of Tyrosine Hydroxylase as a Trojan Horse Decreases Dopamine in Dopaminergic Cells: Pharmaceutical Considerations in Schizophrenia and Parkinson's Disease.Curr Pharm Des. 2022;28(42):3428-3445. doi: 10.2174/1381612829666221102151926. Curr Pharm Des. 2022. PMID: 36330626
-
Systematic review of mitochondrial genetic variation in attention-deficit/hyperactivity disorder.Eur Child Adolesc Psychiatry. 2022 Jul 7. doi: 10.1007/s00787-022-02030-6. Online ahead of print. Eur Child Adolesc Psychiatry. 2022. PMID: 35796884 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical